Friday, May 22, 2015

PMG's CEO discusses the benefits of clinical research participation on the Quintiles Friday Podcast

Having just recognized International Clinical Trials Day, PMG's CEO, Jennifer Byrne, had the opportunity to discuss the numerous benefits of clinical trial participation in the Quintiles Friday Podcast. Jennifer explains how integrating clinical research into the continuum of care leads to better patient engagement and improvements in population health.


Thursday, May 7, 2015

Whether you've taken a medication today to manage a chronic disease or simply to keep a headache at bay, you know that medical innovations have the power to change lives. But these breakthroughs don’t just happen. Developing new medicines is a lengthy and complex process, relying heavily on volunteer participation to evaluate potential therapies for safety and effectiveness in clinical studies. Without the patients who volunteer to participate in clinical trials, the development of new medicines would not be possible.

During Clinical Trials Awareness Week, May 4 – 8, 2015 we recognize the individuals who have made new, innovative treatments a reality for patients worldwide – clinical trial researchers and participants. By shining a spotlight on these unsung heroes, we can raise awareness about the importance of participating in a clinical trial. Clinical trials may benefit participants by providing them the opportunity potentially to receive an investigational drug that is not available to people outside the trial. In addition, they may receive treatment from a clinical research team that provides careful oversight of their medical condition. Also, many participants report great satisfaction playing a key role in advancing medical science and helping scientists find new treatments that will help more people live longer, healthier lives. The Center for Information and Study on Clinical Research
Participation (CISCRP) reports that 95 percent of clinical trial participants would consider joining a future clinical trial.

Everyone should have access to helpful information about clinical trials and the opportunity to determine if participating in a clinical trial is the right choice for them. Join us in spreading the word about the importance of clinical trial participation!

THANK YOU to our participants, physicians, staff and Sponsors for all you do to help PMG fulfill our mission of bringing clinical research to as many lives as possible!


Saturday, April 11, 2015

Smart Talking about Clinical Studies

Smart Talking about Clinical Studies

Think about the power of your words. You have a chance to make a huge difference in the world of advancing medicine and with your help we can reach millions of people. Read more on our blog about how you can explore the power of speaking out about clinical studies. 

You are receiving this newsletter for one of several reasons:
  • You have participated in a clinical study with PMG and provided us with your email address
  • You have expressed an interest in participating in a clinical study with us and provided your email address
  • You signed up to receive our newsletters on our website
Regardless of the reason, we would like you to know that you are a powerful voice in the advancement of clinical research.
CISCRP has put together interesting and informative short videos to share with your friends and family members about clinical studies.
Think about the power of your words. You have a chance to make a huge difference in the world of advancing medicine. With your help we can reach millions of people.
Below is a link created by CISCRP that explores the power of speaking out about clinical studies, so speak outbut speak smart.

Friday, February 6, 2015

#GoRed for Women and Learn about Research Opportunities for Heart Disease with PMG


Heart disease and stroke kill 1 in 3 women, yet it's 80% preventable.


How can we all work together to make a difference?

Today is National Wear Red Day!
  • Nearly 90% have made at least one healthy behavior change.
  • More than one-third have lost weight.
  • More than 50% have increased their exercise.
  • 6 out of 10 have changed their diets.
  • More than 40% have checked their cholesterol levels.
  • One third has talked with their doctors about developing heart health plans.
  • Today, nearly 300 fewer women die from heart disease and stroke each day
  • Death in women has decreased by more than 30 percent over the past 10 years.                


PMG Research is currently offering several clinical research trials that deal with heart disease and its risk factors for men and women. To learn more about what we have to offer please contact us today or visit our website

The team in Winston-Salem wore red today - did you?



Tuesday, December 23, 2014

PMG Research wishes everyone a safe and happy holiday!

We would like to send a sincere thank you to our participants, investigators, healthcare institution, and Sponsors and CRO partners this Holiday Season. Thank you for helping us bring clinical research to as many lives as possible!

Here are some of the winners and team photos from the PMG Research ugly Christmas sweater contest for your enjoyment!


The Hickory Team

The Rocky Mount Team

The Salisbury Team
The Bristol Team

The Wilmington Team

Carla in Bristol

Kristi in Knoxville

Sarfea in Winston-Salem

Sharon in Rocky Mount


Marcus in Wilmington
Amy in Salisbury

Tyler in Charleston


Leslie in the Network Office




Friday, October 10, 2014

Breast Cancer Awareness Month

Did you know that 1 in 8 women will be diagnosed with breast cancer in their lifetime? In 2014 it is estimated that over 232,000 women in the United States will be diagnosed with invasive breast cancer and nearly 40,000 will die as a result of breast cancer. It is the most commonly diagnosed cancer in women worldwide, and the second leading cause of death for women in the U.S. However, it is also important to note that more than 2.8 million women in the U.S. with a history of breast cancer were alive in 2014.1

These numbers illustrate the importance of early detection and screening for the best outcomes. Conducting regular self breast exams and following other screening guidelines for detecting early stage breast cancer are critically important. The American Cancer Society recommends that women receive an annual mammogram beginning at age 40 and are screened regularly. Early detection by mammography also leads to a greater range of treatment options, including less-extensive surgery, the use of chemotherapy with fewer side effects, or even possibly the option to forgo chemotherapy.

These numbers also illustrate the importance of clinical research. Participation in clinical trials provides essential information about the effectiveness and risks of a new treatment. And for breast cancer – like so many other diseases – continued research to discover new and more effective treatments could someday save lives, or even lead to a cure.

You can find more 2014 Breast Cancer Statistics here. If you would like to learn more about clinical trials for breast cancer, you can visit www.clinicaltrials.gov or the American Cancer Society Clinical Trials Matching Service. The National Institutes of Health also features clinical trials, and there are many additional resources, such as www.BreastCancerTrials.org to help you find a trial that may be right for you. To learn more about currently enrolling trials at PMG Research, visit us here.

1http://www.breastcancer.org/symptoms/understand_bc/statistics 

Below: The PMG Research of Raleigh team wearing their pink for Breast Cancer Awareness!












Friday, September 12, 2014

Congratulations on a new FDA Approval - Contrave

PMG is excited to share that Takeda Pharmaceuticals and Orexigen® Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related comorbid condition (such as hypertension, hyperlipidemia, or diabetes).

All ten PMG Research sites, and nearly 1,000 patient volunteers participated in the various studies leading up to the approval of Contrave. We would like to extend a special thank you to our volunteers, physician investigators, and site staff who all contributed to this success. It is always so exciting to see clinical research lead to FDA approval and the potential to help so many people.

To learn more: 


To learn more about currently enrolling studies at PMG Research, visit our website at www.PMG-Research.com



Subscribe Via Email